Vector Gene Technology Company Limited （VGTC）, established in Oct. 2000, is an expert in gene vector technologies, primarily engaged in the research and development of gene transfer technologies and gene therapeutics.
VGTC is a leader in recombinant adeno-associated virus (rAAV) large-scale manufacturing. Its novel AAV package and purification systems make the producing of AAV to be one of the most cost-effective AAV producing systems.
VGTC provides custom manufacturing services of adenoviral vectors, adeno-associated viral vectors and DNA vectors. The manufacturing services, ranging from research grade scale to cGMP-compliant clinical grade scale, makes it easy for our clients to meet their different demands.